Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN (Q82704324)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21125294%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21125294%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Mohsen Tafaghodi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21125294%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ali Khamesipour

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21125294%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Mahmoud R Jaafari

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21125294%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

2 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21125294%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

published in

Parasitology Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21125294%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21125294%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1265-1273

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21125294%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21125294%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00436-010-2176-4

17 January 2020

exact match

0 references

cites work

Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous Leishmaniasis but maintains its potency and durability

1 reference

12 December 2020

Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis.

1 reference

12 December 2020

A Toll-like receptor recognizes bacterial DNA

1 reference

12 December 2020

Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy

1 reference

12 December 2020

Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers.

1 reference

12 December 2020

The regulation of immunity to Leishmania major

1 reference

12 December 2020

Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments

1 reference

12 December 2020

First generation leishmaniasis vaccines: a review of field efficacy trials

1 reference

12 December 2020

Epidemiology of cutaneous leishmaniasis in Iran: B. Khorassan Part V: Report on a focus of zoonotic cutaneous leishmaniasis in Esferayen

1 reference

12 December 2020

Immune responses to an inactive vaccine against American cutaneous leishmaniasis together with granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice.

1 reference

12 December 2020

Immunomodulatory effects associated with a live vaccine against Leishmania major containing CpG oligodeoxynucleotides

1 reference

12 December 2020

Adjuvants for human vaccines--current status, problems and future prospects

1 reference

12 December 2020

Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides

1 reference

12 December 2020

Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination

1 reference

12 December 2020

The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome.

1 reference

12 December 2020

Leishmaniasis vaccine candidates for development: a global overview

1 reference

12 December 2020

Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres

1 reference

12 December 2020

Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.

1 reference

12 December 2020

Role of Mycobacterium vaccae in the protection induced by first generation Leishmania vaccine against murine model of leishmaniasis

1 reference

12 December 2020

Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice

1 reference

12 December 2020

CpG motifs in bacterial DNA and their immune effects

1 reference

12 December 2020

Intraperitoneal immunization with oligomannose-coated liposome-entrapped soluble leishmanial antigen induces antigen-specific T-helper type immune response in BALB/c mice through uptake by peritoneal macrophages

1 reference

12 December 2020

Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers

1 reference

12 December 2020

Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes

1 reference

12 December 2020

Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis

1 reference

12 December 2020

Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response.

1 reference

12 December 2020

Vaccines against leishmaniasis.

1 reference

12 December 2020

Delivery of MUC1 mucin peptide by Poly(d,l-lactic-co-glycolic acid) microspheres induces type 1 T helper immune responses

1 reference

12 December 2020

Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients

1 reference

12 December 2020

Prevention and treatment of cutaneous leishmaniasis in primates by using synthetic type D/A oligodeoxynucleotides expressing CpG motifs

1 reference

12 December 2020

Protection against Leishmania major infection by oligomannose-coated liposomes

1 reference

12 December 2020

Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran

1 reference

12 December 2020

Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection

1 reference

12 December 2020

Two methods for quantifying DNA extracted from poly(lactide-co-glycolide) microspheres

1 reference

12 December 2020

The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis

1 reference

12 December 2020

Immunogenicity and safety of autoclaved Leishmania major plus BCG vaccine in healthy Sudanese volunteers.

1 reference

12 December 2020

Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice

1 reference

12 December 2020

Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis

1 reference

12 December 2020

Induction of systemic and mucosal immune response in cattle by intranasal administration of pig serum albumin in alginate microparticles.

1 reference

12 December 2020

Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection

1 reference

12 December 2020

Mycobacterium hsp65 DNA entrapped into TDM-loaded PLGA microspheres induces protection in mice against Leishmania (Leishmania) major infection.

1 reference

12 December 2020

CpG oligodeoxynucleotides as vaccine adjuvants in primates

1 reference

12 December 2020

Biodegradable microspheres for protein delivery

1 reference

12 December 2020

Vaccination against Leishmania infections

1 reference

12 December 2020

Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice

1 reference

12 December 2020

Comparative safety and immunogenicity trial of two killed Leishmania Major vaccines with or without BCG in human volunteers

1 reference

12 December 2020

The immunology of susceptibility and resistance to Leishmania major in mice

1 reference

12 December 2020

Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG

1 reference

12 December 2020

Leishmania vaccines: progress and problems.

1 reference

12 December 2020

Leishmania major: immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes

1 reference

12 December 2020

Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo

1 reference

12 December 2020